Sale!

CJC-1295 Ipamorelin Blend For Sale | 12mg/6mg

Original price was: $204.09.Current price is: $156.99.

37 in stock (can be backordered)

CJC-1295 + Ipamorelin Blend 12mg/6mg — Synergistic GHRH/GHRP stack. USA-made, 99%+ pure. Top peptide combination for research.

Description

CJC-1295 + Ipamorelin is a synergistic peptide blend combining a GHRH agonist with a GHRP-5 agonist for comprehensive growth hormone research. This 12mg/6mg formulation is one of the most popular peptide stacks in research due to its complementary mechanisms and synergistic effects on GH secretion.nnWhat is CJC-1295 + Ipamorelin?nThis blend combines two distinct GH-stimulating peptides:n• CJC-1295 (GHRH Agonist): Stimulates GH release through GHRH receptorsn• Ipamorelin (GHRP-5 Agonist): Stimulates GH release through ghrelin receptorsnnThe combination targets two separate GH secretion pathways, creating a synergistic effect for enhanced GH stimulation.nnSynergistic MechanismnResearch shows this combination:n• Amplifies GH pulse amplitude through dual-pathway stimulationn• Increases GH secretion frequency and durationn• Preserves natural feedback inhibition (GH-mediated somatostatin suppression)n• Produces more physiologic GH secretion patterns than single agentsn• Maximizes lean muscle support and fat loss in animal modelsnnResearch ApplicationsnThe CJC-1295 + Ipamorelin stack is studied for:n• Growth hormone secretion and GH axis optimizationn• Lean muscle mass development and preservationn• Fat loss and body composition improvementn• Recovery support and tissue repair in animal modelsn• Anti-aging research and age-related GH declinen• Overall metabolic optimizationnnCJC-1295 Component (12mg)nCJC-1295 is a 30-amino acid GHRH analog with DAC-free formulation for fast-acting results. Typical dosing: 100mcg per injection, dosed 5-7x weekly in research protocols.nnIpamorelin Component (6mg)nIpamorelin is a selective GHRP-5 agonist with minimal appetite stimulation compared to other GHRPs. Typical dosing: 50-100mcg per injection, dosed 2-3x daily in research protocols.nnAdministrationnThe combined blend is administered via subcutaneous or intramuscular injection. Research cycles typically run 8-16 weeks for optimal results.nnPurity & QualitynOur CJC-1295 + Ipamorelin blend is USA-manufactured with 99%+ purity. Third-party testing verifies both components independently. Each batch includes full CoA.nnLegal DisclaimernSold for research and educational purposes only. Not for human consumption or medical use. Research Use Only — qualified researchers only in appropriate laboratory settings.

Additional information

Weight

10mg